Literature DB >> 10586903

Assessment of the efficacy of an IgM-elisa and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis.

P Cumberland1, C O Everard, P N Levett.   

Abstract

In a prospective study in Barbados between 1979 and 1989, 321 cases were diagnosed in 638 patients presenting at a hospital with symptoms of leptospirosis. Initial diagnosis was based on patient history and characteristic signs and symptoms. In 92 cases (29%), diagnosis was confirmed by isolation of organisms from the blood, urine, or dialysate fluid; in the remaining 229 cases (71%) diagnosis was confirmed by serology alone. Results of an IgM-ELISA and microscopic agglutination test (MAT) in cases with isolates and in non-leptospirosis cases were used to assess the sensitivity and specificity of the tests. The sensitivity of IgM detection by ELISA was 52% in the first acute-phase specimen, increasing to 89% and 93% in the second acute-phase and convalescent specimens, respectively. The specificity of the IgM-ELISA was high (> or = 94%) in all specimens. The sensitivity of the MAT was low (30%) in the first acute-phase specimen, increasing to 63% in the second acute-phase specimen and 76% in the convalescent specimen. The specificity of the MAT was > or = 97% in all specimens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586903     DOI: 10.4269/ajtmh.1999.61.731

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  61 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis.

Authors:  Mary D Bajani; David A Ashford; Sandra L Bragg; Christopher W Woods; Tin Aye; Richard A Spiegel; Brian D Plikaytis; Bradley A Perkins; Maureen Phelan; Paul N Levett; Robbin S Weyant
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

3.  Seroprevalence of Leptospira spp. in Colorado equids and association with clinical disease.

Authors:  Anna C Fagre; Christie E Mayo; Kristy L Pabilonia; Gabriele A Landolt
Journal:  J Vet Diagn Invest       Date:  2020-07-25       Impact factor: 1.279

4.  Three cases of leptospirosis requiring intensive care.

Authors:  A Scharfetter; M Mühlhans; S Payer; C Wenisch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

5.  Evaluation of a commercial latex agglutination assay for serological diagnosis of leptospirosis.

Authors:  C Hull-Jackson; M B Glass; M D Ari; S L Bragg; S L Branch; C U Whittington; C N Edwards; P N Levett
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

6.  Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis.

Authors:  Julio Croda; João G R Ramos; James Matsunaga; Adriano Queiroz; Akira Homma; Lee W Riley; David A Haake; Mitermayer G Reis; Albert I Ko
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

7.  Serodiagnosis of bovine leptospirosis by IgG-enzyme-linked immunosorbent assay and latex agglutination test.

Authors:  T M A Senthilkumar; M Subathra; P Ramadass; V Ramaswamy
Journal:  Trop Anim Health Prod       Date:  2009-08-14       Impact factor: 1.559

8.  Bat-associated leptospirosis.

Authors:  Neelam A Vashi; Pavani Reddy; Diane B Wayne; Bradley Sabin
Journal:  J Gen Intern Med       Date:  2009-12-09       Impact factor: 5.128

9.  New approach for serological testing for leptospirosis by using detection of leptospira agglutination by flow cytometry light scatter analysis.

Authors:  S Yitzhaki; A Barnea; A Keysary; E Zahavy
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Serological analysis by enzyme-linked immunosorbent assay using recombinant antigen LipL32 for the diagnosis of swine leptospirosis.

Authors:  Cláudia P Hartleben; Fernanda M A Leal; Leonardo G Monte; Daiane D Hartwig; Fabiana K Seixas; Sílvio A Vasconcellos; Bibiana Brihuega; Odir A Dellagostin
Journal:  Curr Microbiol       Date:  2012-10-14       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.